Five core ADME genes coding for phase II drug metabolism enzymes showed significant associations of their intratumoral expression levels with OS rates in cancers, including GSTP1, NAT1, UGT1A1, UGT2B15, UGT2B7 (Figure 3, Table 2). Here, UGT2B7 is linked to cancer.